ALTURiX Ltd are pleased to announce that NACSYS has been awarded hospital contract supplier status for acetylcysteine 600mg effervescent tablets (DHF 021) for CESW (CCM/PHG/17/5532/02), LSNE (CM/PHG/17/5532/02) and NWLN (CM/PHG/17/5532/02).
These tenders were awarded from 1st February 2022.